Rhythm Pharmaceuticals buy Morgan Stanley
Start price
11.07.25
/
50%
€74.50
Target price
11.07.26
€81.37
Performance (%)
1.34%
Price
09:47
?
Summary
This prediction is currently active. With a performance of 1.34%, the BUY prediction by Morgan_Stanley for Rhythm Pharmaceuticals is trending in the right direction. This prediction currently runs until 11.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.685% | 0.685% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was given a new $95.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€118.29
17.03.27
17.03.27
-2.58%
09:47
09:47
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€95.00
16.10.25
16.10.25
€110.50
16.10.26
16.10.26
-20.53%
09:47
09:47
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
67.74%
08.03.26
08.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24